Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2

HL Cameron, MH Perdue - Journal of Pharmacology and Experimental …, 2005 - ASPET
HL Cameron, MH Perdue
Journal of Pharmacology and Experimental Therapeutics, 2005ASPET
Stress-induced intestinal barrier dysfunction may be involved in chronic intestinal disorders.
Glucagon-like peptide-2 (GLP-2) is an intestinotrophic growth hormone that can rapidly
improve intestinal epithelial barrier function. Here, we investigated whether mouse intestine
is responsive to chronic psychological stress and whether pretreatment with GLP-2 can
ameliorate stress-induced changes. Mice were subjected to water avoidance stress (WAS; 1
h/day for 10 days) with GLP-2 or saline administered 4 h before each WAS session. After the …
Stress-induced intestinal barrier dysfunction may be involved in chronic intestinal disorders. Glucagon-like peptide-2 (GLP-2) is an intestinotrophic growth hormone that can rapidly improve intestinal epithelial barrier function. Here, we investigated whether mouse intestine is responsive to chronic psychological stress and whether pretreatment with GLP-2 can ameliorate stress-induced changes. Mice were subjected to water avoidance stress (WAS; 1 h/day for 10 days) with GLP-2 or saline administered 4 h before each WAS session. After the final stress period, the intestine was removed for assessment of physiological/morphological changes. Compared with controls (sham-stressed mice), stressed mice demonstrated enhanced ion secretion and permeability in the jejunum, ileum, and colon. In addition, increased numbers of bacteria were observed adhering to and/or penetrating the epithelium, associated with infiltration of mononuclear cells into the mucosa. GLP-2 treatment improved intestinal barrier function in stressed mice and ameliorated other aspects of impaired host defense. Our study extends previous findings in rats of stress-induced intestinal dysfunction and provides insights into potential novel therapeutics.
ASPET